UBS Group AG - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$11,000
+22.2%
2,270
+43.2%
0.00%
Q2 2021$9,000
-35.7%
1,585
-46.2%
0.00%
Q1 2021$14,000
-12.5%
2,946
-20.0%
0.00%
Q4 2020$16,0003,682
+45925.0%
0.00%
Q3 2020$0
-100.0%
8
-99.1%
0.00%
Q2 2020$2,000
-95.3%
865
-94.1%
0.00%
Q1 2020$43,000
-63.9%
14,560
-53.7%
0.00%
Q4 2019$119,000
+70.0%
31,459
+127.6%
0.00%
Q3 2019$70,000
+1300.0%
13,821
+1497.8%
0.00%
Q2 2019$5,000
-28.6%
865
-17.3%
0.00%
Q1 2019$7,000
-80.0%
1,046
-75.1%
0.00%
Q4 2018$35,000
-49.3%
4,194
+21.0%
0.00%
Q3 2018$69,000
-23.3%
3,4650.0%0.00%
Q2 2018$90,000
-98.1%
3,465
-98.2%
0.00%
-100.0%
Q1 2018$4,649,000
+252.2%
194,503
+399.4%
0.00%
+100.0%
Q4 2017$1,320,000
+118.2%
38,944
+36.3%
0.00%
Q3 2017$605,000
+2226.9%
28,567
+1759.8%
0.00%
Q4 2016$26,000
-16.1%
1,536
-18.7%
0.00%
Q3 2016$31,000
-42.6%
1,889
-0.1%
0.00%
Q4 2015$54,000
+217.6%
1,891
+89.7%
0.00%
Q3 2015$17,000
+70.0%
997
+149.9%
0.00%
Q2 2015$10,000
-33.3%
399
-52.9%
0.00%
Q1 2015$15,000
+50.0%
848
+43.7%
0.00%
Q4 2014$10,0005900.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders